Mounjaro NewsLatest News On Mounjaro Lilly's weight-loss drug cuts diabetes risk by 94% in three-year trial, company says8/20/2024 7:00 AM Eli Lilly Surges On Strong Earnings As Mounjaro And Zepbound Sales Soar8/8/2024 6:33 AM Eli Lilly Surges On Strong Earnings As Mounjaro And Zepbound Sales Soar8/8/2024 5:31 AM Mounjaro And Zepbound Shortages Targeted With $5.3 Billion Eli Lilly Investment5/24/2024 11:46 AM Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum4/29/2024 11:48 AM Ozempic and Mounjaro user sues companies claiming potential for severe stomach issues not disclosed8/10/2023 3:18 AM Eli Lilly Hits Record High After Earnings, Mounjaro Hype8/8/2023 6:05 PM Woman sues drug makers of Ozempic and Mounjaro over severe gastrointestinal issues | CNN Business8/3/2023 11:15 AM Popular diabetes drug Mounjaro could be FDA-approved for weight loss this year, company says4/27/2023 7:35 AM